Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
about
Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionAlkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination.Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systemsChitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials.Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.Harnessing Nanoparticles for Immunomodulation and VaccinesCurrent prospects and future challenges for nasal vaccine delivery.Sodium Acetate Coated Tenofovir-Loaded Chitosan Nanoparticles for Improved Physico-Chemical Properties.Intranasal delivery of nanoparticle-based vaccines.Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice.Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation.Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery.
P2860
Q27001897-9A9A6E56-B055-4F47-A308-580376AE9177Q30397973-7AF4ACA8-0C32-4C3A-8F41-BAAF8F6A023EQ36173746-56ABD6EE-71DC-4DCB-990F-95428BA58F4EQ37189330-187884D8-26D8-459E-AC64-AFB2DAD26A23Q37197084-B17AE33C-1622-4C3B-89F9-EC9847E8B349Q37392189-79BD9763-E14B-4B0A-8527-02E576F456E2Q37423279-BF79BD03-2913-4F50-BC1D-2E1BEB8A8D9DQ37727724-EA6EA617-643D-454B-B46F-5B0569B96D1BQ38784950-C7CA4C8E-A663-417B-AC33-16AFD1AFBBCBQ38944396-04419598-D7D7-4A8A-8D6C-CA20F2A8FDBAQ39113247-4D5323B7-5C45-45C1-A725-29A17F3F4E38Q40309267-ED163154-74D3-4CE7-A5B6-F78B40CCA1E5Q43069547-D11F8C9E-73D7-4867-ACAF-6511E223E9A9Q47449818-FEACA914-548E-4B5F-B395-5D4C6ACD0B8DQ51732339-74E29007-085E-4BDD-8718-D783A16D2F6B
P2860
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@ast
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@en
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@nl
type
label
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@ast
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@en
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@nl
prefLabel
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@ast
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@en
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@nl
P2093
P2860
P356
P1476
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
@en
P2093
Alan Smith
Michael Hinchcliffe
Michael Perelman
P2860
P304
P356
10.4161/HV.27449
P577
2013-12-17T00:00:00Z